Viraj Narayanan, CEO at Cornerstone AI
Daniel Lane, Head of RWD Strategy & Operations at Bristol Myers Squibb
Real-world data (RWD) has become the pharmaceutical industry’s most promising yet challenging frontier. While companies have long…
Continue Reading
Viz.ai, a company involved in AI-backed imaging and care coordination, is collaborating with pharma giant Novartis to develop proprietary AI-powered workflows inside the Viz Oncology Suite.Viz.ai offers a care coordination platform featuring over 50…
Continue Reading
This is an exclusive interview conducted by DistilINFO with Craig P. Gallivan, National Vice President of Sales, Compumedics USA
Craig leads the strategic growth of Compumedics USA’s Home Sleep Testing (HST) division, driving innovation through…
Israeli startup PhaseV, an AI-enabled clinical development company for life sciences, has secured $50 million in Series A funding in a round co-led by Accel and Insight Partners. Existing investors Viola Ventures, LionBird and EXOR…
Continue Reading
Copenhagen-based digital health company specializing in chronic disease management, Dawn Health secured $13 million (€11.5 million) from existing investors Chr. Augustinus Fabrikker, the export and investment fund of Denmark (EIFO) and Trifork. WHAT IT DOES
Dawn…
Digital chronic condition management company DarioHealth announced it closed a debt financing facility for up to $50 million by Callodine Group and Rand Capital. The new funding restructures the company’s prior credit facility and will…
Continue Reading
Direct-to-consumer virtual care company Hims & Hers is partnering with Novo Nordisk to allow Americans to access a bundled offering that includes the pharma giant’s obesity drug Wegovy and a Hims & Hers membership…
Continue Reading
We're excited to be back for another episode of the Life Sciences Today Podcast by Healthcare IT Today. My guest is Matti Gill — CEO at AION Labs. Today, we’re diving into the cutting…
Continue Reading
Hybrid weight-inclusive primary and metabolic care provider knownwell announced it will be listed as a care provider on pharma giant Eli Lilly’s digital healthcare platform LillyDirect.knownwell touts itself as a hybrid weight-inclusive provider offering primary…
Continue Reading
What You Should Know:
– The pharmaceutical research and development (R&D) sector is experiencing a significant upswing, with projected returns on investment climbing to 5.9% in 2024, according to a new report by Deloitte.
– This…
Continue Reading
